AI assistant
Sending…
Cabaletta Bio, Inc. — Director's Dealing 2023
Jul 24, 2023
33628_dirs_2023-07-24_85011e17-cea0-4035-91fa-8778b2948070.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Cabaletta Bio, Inc. (CABA)
CIK: 0001759138
Period of Report: 2023-07-21
Reporting Person: Tomasello Shawn (N/A)
More from Cabaletta Bio, Inc.
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 4
Regulatory Filings
2026
May 4
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Regulatory Filings
2026
Apr 20
Regulatory Filings
2026
Mar 23